= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834
ASSIGNMENT AND ASSUMPTION AGREEMENT
Source: SEC EDGAR database • Date: June 27, 2017 • SIC: 2834 • CIK: 2834